Castle Biosciences (CSTL) Share-based Compensation Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 2.98% |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | -6.08% |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 5.46% |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 10.06% |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | -4.66% |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 32.94% |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -13.59% |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 10.74% |
| 10 | Castle Biosciences | 618.70 Mn | 356.98 Mn | 63.15 Mn | -10.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.26% |
| Dec 31, 2025 | 4.75% |
| Sep 30, 2025 | 9.58% |
| Jun 30, 2025 | 8.47% |
| Mar 31, 2025 | 9.91% |
| Dec 31, 2024 | 18.63% |
| Sep 30, 2024 | 35.73% |
| Jun 30, 2024 | 40.36% |
| Mar 31, 2024 | 37.15% |
| Dec 31, 2023 | 58.55% |
| Sep 30, 2023 | 83.29% |
| Jun 30, 2023 | 98.09% |
| Mar 31, 2023 | 104.69% |
| Dec 31, 2022 | 140.54% |
| Sep 30, 2022 | 242.44% |
| Jun 30, 2022 | 298.30% |
| Mar 31, 2022 | 268.68% |
| Dec 31, 2021 | 353.89% |
| Sep 30, 2021 | 312.20% |